Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
AstraZeneca Provides Update on Brodalumab Development Programme Amgen has announced (http://www.amgen.com/media/media_pr_detail.jsp?year=2015&releaseID=20 5 2862) the termination of its...
-
-
Transaction by Person Discharging Managerial Responsibilities Disclosure Rule DTR 3.1.4 On 8 May 2015, Marc Dunoyer, a Director of the Company, notified us that, on 7 May 2015, he purchased 10,000...
-
The following amendment has been made to the 'Director/PDMR Shareholding' announcement released on 8 May 2015. The grant date of the award of shares has been corrected to September 2014...
-
Transaction by Person Discharging Managerial Responsibilities Disclosure Rule DTR 3.1.4 On 7 May 2015, the interest of Luke Miels, a person discharging managerial responsibilities, in AstraZeneca...
-
AstraZeneca PLC Listing Rule LR 9.6.14 R (2) On 6 May 2015, Geneviève Berger, Non-Executive Director of AstraZeneca PLC, was appointed as a Director of L'Air Liquide S.A., for a term of four...
-
Transaction by Persons Discharging Managerial Responsibilities Disclosure Rule DTR 3.1.4 The following individuals, who are all Directors of the Company, have notified us that they have purchased...
-
Transaction by Persons Discharging Managerial Responsibilities Disclosure Rule DTR 3.1.4 The following individuals, who are all Directors of the Company, have notified us that they have purchased...
-
ASTRAZENECA PLC - ANNUAL GENERAL MEETING 2015 Results of Annual General Meeting held on 24 April 2015 AstraZeneca PLC announced the results of the voting at its Annual General Meeting today. As...
-
Bifogat finns den fullständiga rapporten Det finansiella resultatet för kvartal 1 2015 ger stöd åt upprepad helårsprognos för 2015. · Totala intäkter (definierat som produktförsäljning och intäkter...